Table of Content


Chapter 1. Global Artemisinin Market Executive Summary
1.1. Global Artemisinin Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
?1.3.1. By Malaria Type
?1.3.2. By Product
?1.3.3. By Type
1.4. Key Trends
1.5. COVID-19 Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Artemisinin Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
?2.3.1. Inclusion & Exclusion
?2.3.2. Limitations
?2.3.3. Supply Side Analysis
??2.3.3.1. Raw Material Availability
??2.3.3.2. Cultivation Infrastructure
??2.3.3.3. Regulatory Environment
??2.3.3.4. Manufacturing Capacity
??2.3.3.5. Cost Viability
?2.3.4. Demand Side Analysis
??2.3.4.1. Public Health Programs
??2.3.4.2. Technological Advancements
??2.3.4.3. Environmental Factors
??2.3.4.4. Healthcare Access & Compliance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Artemisinin Market Dynamics
3.1. Market Drivers
?3.1.1. Rising Malaria Incidence in Endemic Regions
?3.1.2. Global Health Initiatives for ACT Procurement
?3.1.3. Innovations in Fixed-Dose Combinations and Long-Acting Injectables
3.2. Market Challenges
?3.2.1. Raw Material Price Volatility Due to Cultivation Risks
?3.2.2. Emerging Artemisinin Resistance in Southeast Asia
3.3. Market Opportunities
?3.3.1. Semi-Synthetic and Fermentation-Based Artemisinin Production
?3.3.2. Expansion of E-Pharmacy and Digital Distribution Models
?3.3.3. Research into Non-Malaria Indications (e.g., Oncology)
Chapter 4. Global Artemisinin Market Industry Analysis
4.1. Porter’s Five Forces Model
?4.1.1. Bargaining Power of Suppliers
?4.1.2. Bargaining Power of Buyers
?4.1.3. Threat of New Entrants
?4.1.4. Threat of Substitutes
?4.1.5. Competitive Rivalry
?4.1.6. Future Outlook on Five Forces
?4.1.7. Impact Analysis
4.2. PESTEL Analysis
?4.2.1. Political
?4.2.2. Economic
?4.2.3. Social
?4.2.4. Technological
?4.2.5. Environmental
?4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Winning Strategies
4.5. Disruptive Trends
4.6. Expert Opinions
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Artemisinin Market Size & Forecasts by Malaria Type, 2022–2032
5.1. Segment Dashboard
5.2. Plasmodium Falciparum
5.3. Plasmodium Vivax
5.4. Plasmodium Ovale
5.5. Plasmodium Malariae
5.6. Plasmodium Knowlesi
Chapter 6. Global Artemisinin Market Size & Forecasts by Product, 2022–2032
6.1. Segment Dashboard
6.2. Injections
6.3. Tablets
Chapter 7. Global Artemisinin Market Size & Forecasts by Type, 2022–2032
7.1. Segment Dashboard
7.2. Combination Therapy
7.3. Monotherapy
Chapter 8. Global Artemisinin Market Size & Forecasts by Region, 2022–2032
8.1. North America Artemisinin Market
?8.1.1. U.S. Artemisinin Market
?8.1.2. Canada Artemisinin Market
8.2. Europe Artemisinin Market
?8.2.1. UK Artemisinin Market
?8.2.2. Germany Artemisinin Market
?8.2.3. France Artemisinin Market
?8.2.4. Spain Artemisinin Market
?8.2.5. Italy Artemisinin Market
?8.2.6. Rest of Europe
8.3. Asia Pacific Artemisinin Market
?8.3.1. China Artemisinin Market
?8.3.2. India Artemisinin Market
?8.3.3. Japan Artemisinin Market
?8.3.4. Australia Artemisinin Market
?8.3.5. South Korea Artemisinin Market
?8.3.6. Rest of Asia Pacific
8.4. Latin America Artemisinin Market
?8.4.1. Brazil Artemisinin Market
?8.4.2. Mexico Artemisinin Market
?8.4.3. Rest of Latin America
8.5. Middle East & Africa Artemisinin Market
?8.5.1. Saudi Arabia Artemisinin Market
?8.5.2. South Africa Artemisinin Market
?8.5.3. Rest of Middle East & Africa
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
?9.1.1. Guilin Pharmaceutical Co., Ltd.
?9.1.2. Sanofi S.A.
?9.1.3. Novartis AG
9.2. Top Market Strategies
9.3. Company Profiles
?9.3.1. Guilin Pharmaceutical Co., Ltd.
??9.3.1.1. Key Information
??9.3.1.2. Overview
??9.3.1.3. Financial (Subject to Data Availability)
??9.3.1.4. Product Summary
??9.3.1.5. Market Strategies
?9.3.2. Cipla Limited
?9.3.3. IPCA Laboratories Ltd.
?9.3.4. Zhenhua Pharma Co., Ltd.
?9.3.5. Artecef B.V.
?9.3.6. KPC Pharmaceuticals, Inc.
?9.3.7. Calyx Chemicals and Pharmaceuticals Ltd.
?9.3.8. Shanghai Natural Bio-engineering Co., Ltd.
?9.3.9. Zhifei Biological Products Co., Ltd.
?9.3.10. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
?9.3.11. Zhejiang Holley Pharmaceutical Co., Ltd.
?9.3.12. Guangdong New South Group Co., Ltd.
?9.3.13. Ajanta Pharma Ltd.
Chapter 10. Research Process
10.1. Research Process Overview
?10.1.1. Data Mining
?10.1.2. Analysis
?10.1.3. Market Estimation
?10.1.4. Validation
?10.1.5. Publishing
10.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global Artemisinin market, research methodology
FIG 2. Global Artemisinin market, estimation techniques
FIG 3. Global Artemisinin market size trends & forecast methods
FIG 4. Global Artemisinin market, key trends 2023
FIG 5. Global Artemisinin market, growth outlook 2022–2032
FIG 6. Global Artemisinin market, Porter’s Five Forces
FIG 7. Global Artemisinin market, PESTEL analysis
FIG 8. Global Artemisinin market, value chain analysis
FIG 9. Artemisinin market by Malaria Type, 2022 vs. 2032 (USD Million)
FIG 10. Artemisinin market by Product, 2022 vs. 2032 (USD Million)
FIG 11. Artemisinin market by Type, 2022 vs. 2032 (USD Million)
FIG 12. Artemisinin regional snapshot 2022 vs. 2032
? (complete list will exceed 20 figures)

List of Tables

List of Tables
TABLE 1. Global Artemisinin market, report scope
TABLE 2. Global Artemisinin market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Artemisinin market estimates & forecasts by Malaria Type 2022–2032 (USD Million)
TABLE 4. Global Artemisinin market estimates & forecasts by Product 2022–2032 (USD Million)
TABLE 5. Global Artemisinin market estimates & forecasts by Type 2022–2032 (USD Million)
TABLE 6. Global Artemisinin market by segment, estimates & forecasts, 2022–2032 (USD Million)
? (complete list will exceed 20 tables)